May 24, 2013 at 11:37 | Source: CNBC-TV18
Portfolio Manager, PN Vijay is bullish on L&T despite the stock falling heavily on Thursday. He is bullish on the real estate sector. Also, he suggests buying pharma stock Wockhardt, on dips.
May 17, 2013 at 16:53 | Source: CNBC-TV18
Aashish Tater, Head of Research, Fortunewizard.com is of the view that Lupin, Sun Pharmaceutical Industries and Dr Reddys Laboratories are safe bets. "We are still making a positive view for Lupin. It is just that the technical snapshot suggests that there has been some gap around Rs 766 and Rs 804 zone, he added.
Apr 18, 2013 at 18:33 | Source: CNBC-TV18
Bino Pathiparampil of IIFL, says that stock like Sun Pharma has been beating estimates for last eight quarters and the same performance is likely to continue in this quarter. Ranbaxys business has been worsening over the last 2-3 quarters and one cant expect major improvement to happen in the base business.
Apr 15, 2013 at 12:40 | Source: Moneycontrol.com
Citigroup Global Markets maintained its "buy" rating on pharma major Wockhardt, saying recent plant inspection and subsequent observations raised by US Food and Drug Administration wouldn't have any immediate impact on the co's business.
Apr 12, 2013 at 18:43 | Source: Moneycontrol.com
Pharma major Wockhardt slumped 10 percent on Friday on reports that the US Food and Drugs Administration had issued a 483 form through a routine course of inspection of one of its plants. The inspection was for its injectables facility in Aurangabad.
Mar 15, 2013 at 23:11 | Source: CNBC-TV18
After the expose in respect to Axis Bank, HDFC Bank and ICICI Bank, SP Tulsian of sptulsian.com takes this as a buying opportunity for all three stocks. He told CNBC-TV18 that although the Bank Nifty has been spoiled because of the bad performance, but all the PSU bank stocks have been ruling reasonably well.
Mar 15, 2013 at 19:04 | Source: CNBC-TV18
SP Tulsian of sptulsian.com is upbeat on Glenmark Pharma, Wockhardt and Lupin.
Feb 22, 2013 at 12:54 | Source: CNBC-TV18
In CNBC-TV18's popular show Bull's Eye, Parag Doctor, Keynote Capital shares trading strategy of the day.
Feb 22, 2013 at 08:27 | Source: CNBC-TV18
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Feb 20, 2013 at 10:31 | Source: Moneycontrol.com
Technology stocks like Infosys, Tech Mahindra, Polaris, MindTree, TCS and Pharma stocks like Cipla, Aurobindo Pharma, Dr Reddy, Ranbaxy, Divis Lab, Wockhardt will be getting astrological support says Satish Gupta of Astrostocktips.